MedPath

Phaco-Trabeculotomy Vs Phaco-Trabeculectomy

Not Applicable
Completed
Conditions
Ophthalmopathy
Glaucoma, Angle-Closure
Glaucoma
Interventions
Procedure: Phacoemulsification combined with trabeculectomy
Procedure: Phacoemulsificaiton combined with ab-externo trabeculotomy
Registration Number
NCT04683055
Lead Sponsor
Assiut University
Brief Summary

A prospective, randomized comparative study on adult patients with synechial angle closure glaucoma.

Detailed Description

Patients were randomized into two groups: group A : patients will undergo two site phacoemulfication combined with trabeculectomy Group B with Phacoemulsification combined with ab-externo trabeculotomy. Preoperative assessments including full ophthalmic examination, anterior segment Optical Coherence Tomography (OCT) of the angle , endothelial cell count , visual fiend Perimetry and Biometry. Patients were followed up: first day, first week and every two months for 6 month. We will compare adverse effects and outcomes in both groups.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with chronic angle closure glaucoma, with or without peripheral anterior synechiae, age more than 18

Exclusion Criteria
  • Patient unable for follow up
  • Patients with corneal or retinal disease that affects visual outcome of surgery
  • Patients with previous glaucoma procedure in the eye of study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Phacoemulsification combined with trabeculectomyPhacoemulsification combined with trabeculectomyPatients will undergo Two site phacoemulsification combined with trabeculectomy with Mitomycin C
Phacoemulsificaiton combined with ab-externo trabeculotomyPhacoemulsificaiton combined with ab-externo trabeculotomyPatients will undergo two phacoemulsification combined with deep sclerectomy and ab-externo trabeculotomy
Primary Outcome Measures
NameTimeMethod
Absolute Success1,3,6 months

Reduction of IOP more than 30% on no glaucoma drops

Visual outcome1,3,6 month

Uncorrected visual acuity by Snellen's chart

Secondary Outcome Measures
NameTimeMethod
Adverse events1 week, 1 month, 3 months, 6 months

all intraoperative and postoperative adverse events witt be recorded

Trial Locations

Locations (1)

Assiut University Hospital

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath